Home›Trial›NCT04068155
🔬NCT04068155NARECRUITING

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Study Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

Conditions
Skin CancerCutaneous TumorCutaneous Metastasis
Interventions / Drugs
DaRT- Diffusing Alpha-emitters Radiation Therapy
View on ClinicalTrials.gov ↗
Sponsor
DRTS
Alpha Tau Medical Ltd.
Biotech / Pharma
F17/100
Study Details
Enrollment80 participants
Primary Completion—
Lead SponsorAlpha Tau Medical LTD.
Data Retrieved2026-06-17 02:56:49.846157+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.